Treatment Options for Patients with Low-risk-Prostate Cancer PREFERE- Study

被引：0
|
作者：
Ohlmann, C. -H. [1 ,2 ]
Bottke, D. [3 ]
Stoeckle, M. [1 ,2 ]
Albers, P. [4 ]
Schmidberger, H. [5 ]
Haerter, M. [6 ]
Kristiansen, G. [7 ]
Bussar-Maatz, R. [1 ,2 ]
Wiegel, T. [3 ]
机构：
[1] Univ Saarland, Klin Urol & Kinderurol, Univ Klinikum Saarlandes, Kirrbergerstr, D-66421 Homburg, Germany
[2] Univ Saarland, Fak Med, Kirrbergerstr, D-66421 Homburg, Germany
[3] Univ Ulm Klinikum, Klin Strahlentherapie & Radioonkol, D-89069 Ulm, Germany
[4] Univ Klinikum Dusseldorf, Urol Klin, Dusseldorf, Germany
[5] Univ Mainz Klinikum, Klin Strahlentherapie & Radioonkol, Mainz, Germany
[6] Univ Klinikum Hamburg Eppendorf, Inst & Poliklin Med Psychol, Hamburg, Germany
[7] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany
来源：
ONKOLOGE | 2016年 / 22卷 / 03期
关键词：
D O I：
10.1007/s00761-016-0023-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [1] Therapy options for patients with low-risk prostate cancer. PREFERE trial
    Ohlmann, C. -H.
    Bottke, D.
    Stoeckle, M.
    Albers, P.
    Schmidberger, H.
    Haerter, C.
    Kristiansen, G.
    Bussar-Maatz, R.
    Wiegel, T.
    [J]. ONKOLOGE, 2015, 21 (09): : 787 - +
  • [2] The PREFERE trial - the desire to prove the efficacy of treatment options for low risk prostate carcinoma
    Weissbach, L.
    [J]. Oncology Research and Treatment, 2015, 38 : 110 - 110
  • [3] Therapy options for patients with low-risk prostate cancer: PREFERE trial [Therapieoptionen für Patienten mit Niedrigrisiko-Prostatakarzinom: PREFERE-Studie]
    Ohlmann C.-H.
    Bottke D.
    Stöckle M.
    Albers P.
    Schmidberger H.
    Härter C.
    Kristiansen G.
    Bussar-Maatz R.
    Wiegel T.
    [J]. Der Onkologe, 2015, 21 (9): : 787 - 796
  • [4] Low and intermediate risk prostate cancer: Treatment options
    Minana-Lopez, Bernardino
    Reina-Alcaina, Leandro
    Rivero-Guerra, Angela
    Rosino-Sanchez, Antonio
    Izquierdo-Morejon, Emilio
    Pietricica, Bogdan
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (06): : 260 - 270
  • [5] Treatment options for low-risk prostate cancer
    Song, Yuxuan
    Xu, Tao
    [J]. WORLD JOURNAL OF UROLOGY, 2022, 40 (11) : 2827 - 2828
  • [6] Treatment options for low-risk prostate cancer
    Yuxuan Song
    Tao Xu
    [J]. World Journal of Urology, 2022, 40 : 2827 - 2828
  • [7] Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial)
    Andreas Boehle
    Frank Kahmann
    Thomas Oliver Henkel
    Joerg Zimmermann
    Stefan Machtens
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1271 - 1272
  • [8] Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
    Wiegel, Thomas
    Albers, Peter
    Bartkowiak, Detlef
    Bussar-Maatz, Roswitha
    Haerter, Martin
    Kristiansen, Glen
    Martus, Peter
    Wellek, Stefan
    Schmidberger, Heinz
    Grozinger, Klaus
    Renner, Peter
    Schneider, Fried
    Burmester, Martin
    Stoeckle, Michael
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (01) : 235 - 242
  • [9] Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
    Thomas Wiegel
    Peter Albers
    Detlef Bartkowiak
    Roswitha Bussar-Maatz
    Martin Härter
    Glen Kristiansen
    Peter Martus
    Stefan Wellek
    Heinz Schmidberger
    Klaus Grozinger
    Peter Renner
    Fried Schneider
    Martin Burmester
    Michael Stöckle
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 235 - 242
  • [10] Comparison of four Treatment Options for low risk Prostate Cancer
    Rexer, H.
    Bussar-Maatz, R.
    [J]. UROLOGE, 2015, 54 (05): : 723 - 725
12345